sagai
Quite Involved in Discussions
Guys,
My utterly subjective opinion is coming ...
We can do an awful lot of things, however, we cannot mitigate software risk at all by software.
It is due to the nonsense nature of this medical industry approach, that there is a category like Software as a Medical Device or Medical Software Device in EU in isolation from the hardware.
Not a surprise though, have a look at how many of the regulatory guys are lawyers and how many of them having an engineering background.
Other thing ...
For this 14971 approach, strictly the main compulsory text is calling for HARA. Millions of times people believe that it equals FMEA of some kind. Nonsense, put it in to polite.
The similar thing starts to evolve here when we focus on device failure, rather than on the potential harm on patients by using the device (this piece of software that I doubt would do anything without running on hardware) that is 100% functional.
So what can we do than with this software thing ...
There is a risk-benefit analysis that the domain medical expert can think of for quite a while, if this piece of software still beneficial to use for medical purposes, with all the limitation, with all the miserable nature of all of its use cases on patients, etcetera.
Cheers
Saby
My utterly subjective opinion is coming ...
We can do an awful lot of things, however, we cannot mitigate software risk at all by software.
It is due to the nonsense nature of this medical industry approach, that there is a category like Software as a Medical Device or Medical Software Device in EU in isolation from the hardware.
Not a surprise though, have a look at how many of the regulatory guys are lawyers and how many of them having an engineering background.
Other thing ...
For this 14971 approach, strictly the main compulsory text is calling for HARA. Millions of times people believe that it equals FMEA of some kind. Nonsense, put it in to polite.
The similar thing starts to evolve here when we focus on device failure, rather than on the potential harm on patients by using the device (this piece of software that I doubt would do anything without running on hardware) that is 100% functional.
So what can we do than with this software thing ...
There is a risk-benefit analysis that the domain medical expert can think of for quite a while, if this piece of software still beneficial to use for medical purposes, with all the limitation, with all the miserable nature of all of its use cases on patients, etcetera.
Cheers
Saby